KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Shareholder's Equity (QoQ) (2009 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 6.14%
Dec 31, 2025 -9.99%
Sep 30, 2025 29.50%
Jun 30, 2025 19.67%
Mar 31, 2025 5.62%
Dec 31, 2024 -21.92%
Sep 30, 2024 27.04%
Jun 30, 2024 17.98%
Mar 31, 2024 -19.42%
Dec 31, 2023 -18.60%
Sep 30, 2023 12.90%
Jun 30, 2023 26.80%
Mar 31, 2023 46.08%
Dec 31, 2022 0.22%
Sep 30, 2022 51.01%
Jun 30, 2022 164.08%
Mar 31, 2022 -86.33%
Dec 31, 2021 -18.46%
Sep 30, 2021 -0.36%
Jun 30, 2021 -11.65%
Mar 31, 2021 -0.80%
Dec 31, 2020 -14.14%
Sep 30, 2020 2.81%
Jun 30, 2020 12.38%
Mar 31, 2020 -1.94%
Dec 31, 2019 -11.48%
Sep 30, 2019 1.23%
Jun 30, 2019 -0.35%
Mar 31, 2019 -13.34%
Dec 31, 2018 -12.89%
Sep 30, 2018 -3.76%
Jun 30, 2018 -4.55%
Mar 31, 2018 -38.12%
Dec 31, 2017 -21.68%
Sep 30, 2017 32,129.00%
Jun 30, 2017 127.62%
Mar 31, 2017 -101.21%
Dec 31, 2016 -2.92%
Sep 30, 2016 10,812.41%
Jun 30, 2016 138.98%
Mar 31, 2016 -99.58%
Dec 31, 2015 0.41%
Sep 30, 2015 1.76%
Jun 30, 2015 3.69%
Mar 31, 2015 2.82%
Dec 31, 2014 1.79%
Sep 30, 2014 3.87%
Jun 30, 2014 7.22%
Mar 31, 2014 2.92%
Dec 31, 2013 1.69%
Sep 30, 2013 5.51%
Jun 30, 2013 5.66%
Mar 31, 2013 2.26%
Dec 31, 2012 -4.23%
Dec 31, 2011 -19.21%
Sep 30, 2011 -8.05%
Jun 30, 2011 2.52%
Mar 31, 2011 4.34%
Dec 31, 2010 -0.53%
Sep 30, 2010 3.89%
Jun 30, 2010 3.72%
Mar 31, 2010 -1.45%
Dec 31, 2009 -0.84%
Sep 30, 2009 7.01%